Euphausia superba protein amyloid fiber-iron compound as well as preparation method and application thereof
Through the composite treatment of Antarctic krill protein amyloid fiber and iron, Antarctic krill protein amyloid fiber-iron complex is formed, which solves the problems of easy oxidation of existing iron enhancers and strong gastrointestinal irritation, and achieves efficient bioavailability of iron and relieves gastric inflammation.
Patent Information
- Application Number
- CN202510090855.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-01-21
- Publication Date
- 2025-05-06
AI Technical Summary
Existing iron enhancers have problems such as easy oxidation, poor sensory characteristics, and strong gastrointestinal irritation, which leads to reduced iron utilization and gastric inflammation, making it difficult to achieve steady-state iron delivery.
Antarctic krill protein amyloid fibers are extracted by using Antarctic krill protein and antarctic krill protein amyloid fiber-iron complex is formed by acid heat treatment, so as to achieve valence protection and steady-state delivery of iron.
It improves the bioavailability of iron, alleviates the inflammatory response of stomach caused by iron deficiency anemia, and provides functional health products and nutritional fortification foods with high iron content.
Smart Images

Figure CN119924532A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to an Antarctic krill protein amyloid fiber-iron complex and a preparation method and application thereof, belonging to the field of food biotechnology. Background Art
[0002] Iron is a trace element necessary for organisms to maintain normal life activities. It is an important component of cytochrome, hemoglobin and enzymes, and plays an important role in transporting oxygen and electrons. Iron deficiency is the main cause of anemia. Iron deficiency anemia is the most common type of anemia, which can cause fatigue, pale skin and stunted development. In severe cases, it can cause breathing difficulties, angina pectoris, etc., affecting people's quality of life and physical health.
[0003] Iron supplementation and food iron fortification are currently the dominant dietary strategies for dealing with iron deficiency. Iron supplementation in the human body mainly comes from dietary iron in food. However, dietary iron will be strongly interfered with by other food components such as phytates, polyphenols and other substances during the digestion and absorption process, resulting in reduced iron utilization. Conventional iron fortifiers (such as ferrous sulfate) have problems such as easy oxidation, poor sensory properties, and strong gastrointestinal irritation, which seriously limit the application of iron-fortified foods and functional foods. In recent years, the use of functional ingredients from food sources as carriers for food iron fortification has attracted widespread attention. Common ones include peptide-iron complexes, polysaccharide-iron complexes, etc., which can improve the sensory properties of iron and increase the bioavailability of iron. However, during the digestion process, due to H + Competing for charge-donating groups causes metal ions to dissociate, and the destroyed complexes lead to more iron being released and dissolved. The released iron can irritate the gastric mucosa. During simulated digestion, iron is also easily oxidized or forms insoluble iron compounds under alkaline conditions, resulting in ineffective absorption in the small intestine. Based on this, it is a huge challenge to explore and develop iron-fortified foods that can deliver iron in a steady state while alleviating the irritation of iron to the gastrointestinal tract.
[0004] Studies have shown that food-borne amyloid fibers are safe and non-toxic. They are usually formed by the fibrillation of natural food proteins under low pH, low ionic strength and high temperature conditions. After protein fibrillation, the rich active groups inside the protein are exposed on the surface, and can load nutritional functional substances through molecular interactions. In extreme environments (such as acid, heat, and proteases), amyloid fibers have stronger resistance than natural proteins. At the same time, due to its specific steric hindrance, it has higher antioxidant properties and can protect the stable existence of nutritional functional substances. In recent years, food-derived amyloid fibers have become excellent carriers for delivering nutrients, such as a method for encapsulating carotene and improving the stability of carotene using egg white lysozyme amyloid fibers as materials (publication number: CN112106988A), a method for preparing zeaxanthin dipalmitate high internal phase emulsion using protein amyloid fiber-polysaccharide complex (publication number: CN111467334A), amyloid fiber-ferulic acid-chitosan double network hydrogel and its preparation method and application (publication number: CN115353646A), etc. However, there are few reports on amyloid fibers as mineral delivery carriers. Summary of the invention
[0005] In order to solve the above problems, the present invention provides a method for preparing Antarctic krill protein amyloid fiber-iron complex, which uses Antarctic krill to extract Antarctic krill protein, and induces Antarctic krill protein to form Antarctic krill protein amyloid fiber through acid-heat treatment, which can protect the valence state of iron and can be applied to functional health products, nutritionally fortified foods and other fields. The present invention uses an iron deficiency anemia mouse model to evaluate the bioavailability of Antarctic krill protein amyloid fiber-iron complex and its function of relieving gastric inflammation.
[0006] The present invention provides a method for preparing an Antarctic krill protein amyloid fiber-iron complex, comprising the following steps:
[0007] (1) Extraction of Antarctic krill protein
[0008] Deionized water is added to the Antarctic krill meat, the pH is adjusted and then the mixture is stirred evenly, the supernatant is collected by centrifugation, the pH of the supernatant is adjusted to the isoelectric point of the Antarctic krill protein and then the precipitate is collected by centrifugation, water is added to the obtained precipitate to adjust the pH, and the Antarctic krill protein is obtained by freeze-drying after dialysis;
[0009] (2) Formation of amyloid fibrils in Antarctic krill
[0010] Antarctic krill protein solution prepared with deionized water is uniformly stirred, pH is adjusted, heated, and freeze-dried to obtain Antarctic krill protein amyloid fibers;
[0011] (3) Formation of Antarctic krill protein amyloid fibrils-iron complexes
[0012] Antarctic krill protein amyloid fibers are taken, deionized water is added to dissolve, ascorbic acid is added to adjust the pH, and then iron salt is added to react. After the reaction is completed, the supernatant is collected by centrifugation, anhydrous ethanol is added, and the precipitate is collected by centrifugation. After washing, it is dried to obtain Antarctic krill protein amyloid fiber-iron complex.
[0013] In one implementation method, in step (1), the method for preparing Antarctic krill protein specifically comprises the following steps:
[0014] Add water to the Antarctic krill mince, the mass volume ratio of Antarctic krill meat to water is 1g:5-10mL, adjust the pH to 11-12.5, stir evenly for 2-3h, centrifuge at 8000-10000×g at 4°C for 10-15min, collect the supernatant, adjust the pH of the supernatant to the isoelectric point of Antarctic krill protein with 6-8mol / L hydrochloric acid solution, centrifuge at 8000-10000×g at 4°C for 10-15min, collect the precipitate, add 500-1000mL of water to the precipitate and stir evenly, adjust the pH to 7.0, put it into a 3500Da dialysis bag for dialysis for 24-48h, and freeze-dry to obtain Antarctic krill protein.
[0015] In one implementation method, in step (2), the pH is adjusted to 2.0-3.0.
[0016] In one embodiment, in step (2), heating is performed at 70-90°C.
[0017] In one implementation method, in step (2), the mass concentration of the Antarctic krill protein solution is 1-5%.
[0018] In one implementation method, in step (3), the iron salt added is one of FeSO4·7H2O, FeCl2·4H2O or other inorganic iron salts.
[0019] In one implementation method, in step (3), the mass ratio of the added iron salt to the Antarctic krill protein amyloid fibers is 1:5 to 10:1, and more preferably 1:2.
[0020] In one implementation method, in step (3), the reaction temperature is 20 to 60° C., more preferably 30° C.; the reaction time is 20 to 60 min, more preferably 40 min.
[0021] In one implementation method, in step (3), the pH is adjusted to 2.0 to 7.0, more preferably 5.0.
[0022] In one implementation method, in step (3), the mass ratio of iron salt to ascorbic acid is in the range of 1:1 to 2.
[0023] The present invention provides an Antarctic krill protein amyloid fiber-iron complex prepared by the method described above.
[0024] The present invention provides the use of the Antarctic krill protein amyloid fiber-iron complex described above in the preparation of iron-rich food or iron supplement medicine.
[0025] Beneficial effects of the present invention:
[0026] (1) The present invention uses Antarctic krill protein as raw material to prepare Antarctic krill protein amyloid fibers, which expands the application scope of the protein and provides a reference direction for the high-value utilization of Antarctic krill.
[0027] (2) The Antarctic krill amyloid fibers prepared by the present invention have a valence protection effect on iron. The formed Antarctic krill protein amyloid fiber-iron complex has a high iron content, and the maximum iron content can reach about 60%.
[0028] (3) The Antarctic krill amyloid fiber-iron complex prepared by the present invention can improve the bioavailability of iron, relieve gastric inflammatory response caused by iron deficiency anemia, and provide a basis for the application of the Antarctic krill amyloid fiber-iron complex.
[0029] (4) The preparation method of the present invention is simple and quick, and the prepared Antarctic krill amyloid fiber-iron complex can be used in the fields of iron supplements, nutritionally fortified foods, etc. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 is the fluorescence image of Thioflavin T of Antarctic krill amyloid fibers in Example 1;
[0031] Figure 2 This is the microscopic morphology of Antarctic krill amyloid fibers in Example 1;
[0032] Figure 3 is the iron reducing capacity of Antarctic krill amyloid fibers in Example 1;
[0033] Figure 4 is the infrared spectrum of the Antarctic krill amyloid fiber-iron complex in Example 1;
[0034] Figure 5 is a fluorescence spectrum of the Antarctic krill amyloid fiber-iron complex in Example 1;
[0035] Figure 6 is the energy spectrum of Antarctic krill amyloid fiber-iron complex in Example 1;
[0036] Figure 7 The effect of Antarctic krill amyloid fiber-iron complex on the body weight of iron-deficiency anemia mice in Example 1;
[0037] Figure 8The effect of Antarctic krill amyloid fiber-iron complex on the iron content of spleen in iron-deficiency anemia mice in Example 1;
[0038] Fig. 9 The effect of Antarctic krill amyloid fiber-iron complex on the liver of iron deficiency anemia mice in Example 1;
[0039] Fig.10 The effect of Antarctic krill amyloid fiber-iron complex on the spleen of iron deficiency anemia mice in Example 1;
[0040] Fig.11 The effect of Antarctic krill amyloid fiber-iron complex on the expression of iron homeostasis genes in iron deficiency anemia mice according to Example 1;
[0041] Fig.12 This is Example 1, the effect of Antarctic krill amyloid fiber-iron complex on the expression of gastric inflammatory genes in iron-deficiency anemia mice. DETAILED DESCRIPTION
[0042] To make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be clearly and completely described below, but the implementation and protection scope of the present invention are not limited thereto. If the specific conditions are not specified in the embodiments, they are carried out according to the conventional conditions or the conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be purchased commercially. The raw materials used in the embodiments are all food grade.
[0043] Example 1: A method for preparing Antarctic krill protein amyloid fiber-iron complex
[0044] (1) Extraction of Antarctic krill protein (AKP)
[0045] Add water to the Antarctic krill mince, the Antarctic krill meat and water are in a mass volume ratio of 1g:10mL, adjust the pH to 12.5, stir evenly for 2h, centrifuge at 10000×g for 10min at 4°C, collect the supernatant, adjust the pH of the supernatant to the isoelectric point of Antarctic krill protein with 6mol / L hydrochloric acid solution, centrifuge at 10000×g for 10min at 4°C, collect the precipitate, add 500mL of water to the precipitate and stir evenly, adjust the pH to 7.0, put it into a 3500Da dialysis bag for dialysis for 48h, and freeze-dry to obtain Antarctic krill protein;
[0046] (2) Preparation of Antarctic krill protein amyloid fibrils (AKAF)
[0047] A 1% Antarctic krill protein solution prepared with deionized water was stirred uniformly at 4°C for 6 hours, the pH was adjusted to 2.0, heated at 90°C for 15 minutes, and freeze-dried to obtain Antarctic krill protein amyloid fibers;
[0048] (3) A method for preparing Antarctic krill protein amyloid fiber-iron complex (AKAF-Fe)
[0049] Antarctic krill protein amyloid fibers were taken and dissolved in deionized water to prepare an Antarctic krill protein amyloid fiber solution (1%, w / v). Ascorbic acid was added to the solution to prevent Fe in the system from 2+ Oxidation, adjusting pH 5 and adding FeSO4·7H2O for mixing, wherein the mass ratio of FeSO4·7H2O to ascorbic acid is 1:2, and the mass ratio of FeSO4·7H2O to Antarctic krill protein amyloid fiber is 1:2; the system is reacted at 30℃ for 40min, the supernatant is collected by centrifugation, and 6 volumes of anhydrous ethanol are added, and the sample is allowed to stand for complete precipitation. The ethanol is removed by centrifugation to obtain the AKAF-Fe complex, which is washed with ethanol. This operation is repeated 4 times to remove excess iron ions, and the remaining alcohol is volatilized by nitrogen blowing to obtain AKAF-Fe powder, whose iron content is 60.66%.
[0050] Example 2
[0051] The preparation method is the same as that of Example 1, except that the pH adjusted in step (3) is replaced to 2, 3, 4, 6, and 7 respectively.
[0052] Experimental results: The iron content of Antarctic krill protein amyloid fiber-iron complexes prepared at pH 2, 3, 4, 6, and 7 were 4.96%, 9.57%, 55.67%, 46.64%, and 39.68%, respectively, which were lower than the iron content of Antarctic krill protein amyloid fiber-iron complexes prepared at pH 5.
[0053] Example 3
[0054] The preparation method of Example 1 is the same, except that the reaction time in step (3) is replaced to 20 min, 30 min, 50 min, and 60 min, respectively.
[0055] Experimental results: The iron content of Antarctic krill protein amyloid fiber-iron complex prepared under reaction time of 20min, 30min, 50min and 60min were 47.58%, 56.71%, 40.62% and 42.03%, respectively, which were lower than the iron content of Antarctic krill protein amyloid fiber-iron complex prepared under reaction time of 40min.
[0056] Example 4
[0057] The preparation method of Example 1 is the same, except that the reaction temperature in step (3) is replaced to 20°C, 40°C, 50°C, and 60°C, respectively.
[0058] Experimental results: The iron content of Antarctic krill protein amyloid fiber-iron complex prepared at reaction temperatures of 20°C, 40°C, 50°C and 60°C were 52.57%, 52.38%, 51.63% and 50.69%, respectively, which were lower than the iron content of Antarctic krill protein amyloid fiber-iron complex prepared at a reaction temperature of 30°C.
[0059] Example 5
[0060] The preparation method is the same as that of Example 1, except that in step (3), the mass ratios of Antarctic krill protein amyloid fibers and FeSO4·7H2O are replaced to 1:10, 1:5, 1:2, and 5:1, respectively.
[0061] Experimental results: The iron contents of Antarctic krill protein amyloid fibers-iron complexes prepared under the conditions of the mass ratio of Antarctic krill protein amyloid fibers to FeSO4·7H2O were 1:10, 1:5, 1:2, and 5:1, respectively, were 37.23%, 43.16%, 47.11%, and 57.74%, respectively, which were lower than the iron content of Antarctic krill protein amyloid fibers-iron complexes prepared under the mass ratio of 2:1.
[0062] Comparative Example 1
[0063] The preparation method is the same as that of Example 1, except that the Antarctic krill protein is replaced with soy protein isolate.
[0064] Comparative Example 2
[0065] The preparation method is the same as that of Example 1, except that the Antarctic krill protein is replaced with pea protein.
[0066] The iron contents of the complexes obtained in Comparative Examples 1 and 2 were 42.48% and 55.77%, respectively, which were lower than the iron content of the Antarctic krill protein amyloid fiber-iron complex prepared from the Antarctic krill protein in Example 1.
[0067] The following characterization and performance tests were all performed on AKAF and AKAF-Fe prepared in Example 1.
[0068] 1. Thioflavin T fluorescence image of Antarctic krill protein amyloid fibrils (AKAF)
[0069] 8 mg of thioflavin T (ThT) powder was dissolved in 10 mL of phosphate buffer solution (PB, 10 mM, pH 7.0, 150 mM NaCl). Undissolved ThT was removed with a 0.22 μm filter and stored at 4 °C in the dark. On the day of analysis, the ThT stock solution was diluted 50 times with PB to generate the ThT working solution. The sample solution (0.1 mg / mL) was mixed with the ThT working solution in a volume ratio of 1:100 and equilibrated for 2 minutes in the dark. The excitation wavelength at 440 nm was scanned using a fluorescence spectrophotometer (1500 nm / min), and the ThT fluorescence intensity of the working solution was used as the fluorescence background value.
[0070] Experimental results: Figure 1 As shown in the figure, with the delay of heating time, the ThT fluorescence intensity of AKAF showed a trend of first increasing and then decreasing. The increase in fluorescence intensity indicates that AKP formed an ordered β-folded structure after heating for 15 minutes. The heating time to reach the maximum fluorescence intensity at 90°C is 4 times that at 70°C, indicating that high temperature can accelerate the formation of fibers. This is consistent with the existing results: due to the characteristics of protein denaturation at high temperature, higher temperatures will accelerate the rearrangement of protein structural units, increase the nucleation rate of fibers, and thus promote the formation of fibers. However, after heating for 30 minutes, the fluorescence intensity of ThT decreased. This phenomenon may be attributed to two reasons: one is that excessive hydrolysis leads to the destruction of the ordered fiber structure, and the other is that the aggregation of fibers shields the ThT binding site.
[0071] 2. Microscopic morphology of Antarctic krill protein amyloid fibers
[0072] 10 μL of sample was dropped onto the sample stage and quickly frozen with liquid nitrogen. After sublimation (-90°C, 30 min), the sample was cut to form a cross section and gold was splashed on the surface. The microscopic morphology of the sample was observed at 10 kV.
[0073] Experimental results: Under cold field scanning electron microscopy, it was observed that the unheated AKP had spherical proteins and protein fragments of uneven sizes. At 15 minutes, AKP showed a slender straight fiber shape ( Figure 2 ).
[0074] 3. Iron-reducing ability of Antarctic krill protein amyloid fibrils
[0075] 10 μL of sample (2 mg / mL and 20 mg / mL) was mixed with 30 μL of 0.1 M FeCl3·6H2O and then 1.8 mL of 5 mM o-phenanthroline was added. The mixture was incubated at 37°C for 8 h and measured at 512 nm by a microplate reader every 30 min. Samples without Fe and without fiber were used as controls to exclude the influence of the reaction system itself.
[0076] Experimental results: The effects of AKAF at different concentration levels on iron reduction were studied. Figure 3 As shown in Figures 3A (2 mg / mL) and 3B (20 mg / mL), we observed that the iron reducing capacity of AKAF increased with the extension of reaction time at both concentrations. The results indicate that the fibrils have the ability to reduce iron and this reducing effect is concentration-dependent. Therefore, AKAF can be an ideal candidate for iron fortification because it can keep iron in the more bioavailable Fe(II) state.
[0077] 4. Determination of Iron Content in Antarctic Krill Protein Amyloid Fiber-Iron Complex
[0078] The iron content of AKAF-Fe was determined using the o-phenanthroline colorimetric method. 1 mg / mL iron standard solution was diluted to 0, 0.02, 0.04, 0.06, 0.08, and 0.1 mg / mL solutions. 1 mL of 0.2 mol / L acetic acid-sodium acetate buffer (pH 5.0) and 200 μL of 20 mg / mL ascorbic acid were added to the solution in sequence. After thorough mixing, 400 μL of 5 mg / mL o-phenanthroline solution was added to prepare the working colorimetric solution. The reaction was allowed to stand for 15 minutes. Ultrapure water was used as a blank control, and the absorbance of the reaction solution was measured at 510 nm. According to the Fe 2+ Concentration and absorbance are plotted against the standard curve. To dissociate the iron ions, AKAF-Fe powder is acidified with a small amount of 6M HCl and the volume is fixed with water. The working solution is added in sequence according to the above steps, and the sample absorbance is measured at 510nm, and the iron content in the solution is determined by the standard curve. The iron content in the sample is calculated by the formula:
[0079] Iron content = solution iron content * solution volume / sample total mass * 100%
[0080] 5. Infrared spectrum of Antarctic krill protein amyloid fibril-iron complex (AKAF-Fe)
[0081] The sample was mixed with potassium bromide, ground and extruded into sheets. The sample was scanned using a Fourier transform infrared spectrometer at 400-4000 cm -1 Range scan, instrument resolution is 4cm -1 , and obtain the infrared spectrum.
[0082] Experimental results: Figure 4 The results showed that -NH and -OH of AKAF formed new coordination bonds with iron, and the C=O group also participated in the binding, which was attributed to the binding of the non-bonded free electrons of carbonyl oxygen to iron ions. In addition, the red shift of the characteristic peak of the –COO- group of AKAF may be due to the formation of –COO-Fe. Therefore, the binding site of iron may be related to the C-terminal carboxyl group, glutamic acid and aspartic acid residues. At the same time, at 1131cm-1 A strong band of AKAF-Fe was also found at 618 cm-1, which is most likely due to the formation of C–O–Fe coordination sites. -1 The appearance of characteristic peaks is attributed to the stretching vibration of the C–N bond, which is due to the binding interaction between the N atom in the imidazole group and iron. Therefore, the binding of AKAF to iron mainly occurs on the carboxyl, amino, hydroxyl and imidazole groups.
[0083] 6. Fluorescence Spectrum of Antarctic Krill Protein Amyloid Fibrils-Iron Complex (AKAF-Fe)
[0084] The spectral information of the samples was measured using a fluorescence spectrophotometer under the conditions of an excitation wavelength of 280 nm, a scanning range of 290-450 nm, and a scanning speed of 1500 nm / min.
[0085] Experimental results: Figure 5 As shown in the figure, the introduction of iron significantly reduced the fluorescence intensity of AKAF itself, quenched the intrinsic fluorescence of the protein, and was accompanied by a shift in the maximum absorption peak. This indicates that protein folding occurred during the binding process, and there was a strong interaction and energy transfer between AKAF and iron.
[0086] 7. Energy spectrum of Antarctic krill protein amyloid fibril-iron complex (AKAF-Fe)
[0087] The sample powder was evenly coated on the tape and left for gold spraying at 15 mA for 90 s. The energy dispersive X-ray spectrometer was used for scanning at an accelerating voltage of 5 kV.
[0088] Experimental results: AKAF and AKAF-Fe energy spectra and relative element contents are shown in Figure 6 A and 6B. The three basic protein components C, N, and O can be clearly observed in AKAF, with contents of 56.80%, 24.07%, and 17.49%, respectively. AKAF-Fe contains 19.79% iron, which indicates that AKAF can bind to iron.
[0089] 8. Establishment of Iron Deficiency Anemia Mouse Model
[0090] 40 SPF-grade three-week C57BL / 6 female mice were purchased from Liaoning Changsheng Biotechnology Co., Ltd. and raised in an SPF-grade animal laboratory. During the experiment, the mice were free to eat and drink water. After one week of adaptation to the environment, 10 mice were randomly selected to feed normal feed (45ppm Fe) until the end of the experiment and set as the normal control group (NC). The experimental group mice were fed with low-iron feed (12ppm Fe) to establish an iron deficiency anemia mouse model. During the 8-week period of feeding, blood was collected from the eye sockets of the mice and measured using a hemoglobin (Hb) kit (Nanjing Jiancheng). It is generally believed that Hb less than 100g / L is iron deficiency anemia. After the iron deficiency model was established, the experimental group was randomly divided into 3 groups according to hemoglobin content and mouse weight, and continued to feed low-iron feed for 3 weeks. During this period, the normal control group (NC) and the iron deficiency model group (MD) were given deionized water every day. The remaining two groups were given daily intragastric administration of FeSO4 solution (2.3 ppm Fe) and AKAF-Fe solution (2.3 ppm Fe) as additional iron sources, and were set as FE group and AF group. The body weight of mice was recorded weekly for 3 weeks of iron supplementation. 18 h after the last intragastric administration, the mice were euthanized, and the liver, spleen, and stomach were collected for subsequent experiments.
[0091] Experimental results: The weight changes of mice were as follows Figure 7 As shown in the figure, after the iron-deficient diet (0week), the body weight of the iron-deficient diet group was not significantly different, but its body weight was significantly reduced compared with the normal control group. Therefore, IDA affects the growth and development of mice. Then, IDA mice were iron supplemented by taking FeSO4 and AKAF-Fe for 3 consecutive weeks. We found that the body weight of the AF group was significantly different from that of the MD group and the FE group, indicating that AKAF-Fe can improve the problem of slow growth and development of mice and the effect is better than taking free iron alone.
[0092] 9. Effect of Antarctic krill protein amyloid fibril-iron complex (AKAF-Fe) on spleen iron content in iron-deficiency anemia mice
[0093] 0.1 g of spleen was weighed and digested by wet method to form working solution, and the iron content in the tissue was determined by atomic absorption spectrophotometry.
[0094] Experimental results: IDA can lead to a decrease in spleen iron content in mice ( Figure 8 ). Intake of FeSO4 and AKAF-Fe alleviated the spleen dysplasia and iron storage capacity, restoring them to normal levels. AKAF-Fe had a better effect of intervening iron storage capacity compared to mice ingesting FeSO4.
[0095] 10. Effects of Antarctic krill protein amyloid fibril-iron complex (AKAF-Fe) on organs of mice with iron deficiency anemia
[0096] The liver and spleen were fixed with 4% paraformaldehyde solution, and after embedding and sectioning, the tissue sections were stained with hematoxylin-eosin, and the pathological changes of the tissues were observed under an optical microscope.
[0097] Experimental results: Fig. 9 As shown, the hepatocytes of normal mice are arranged regularly and have complete morphology. Compared with the NC group, we observed that the hepatocytes in the MD group had unclear boundaries, disordered dilation of the hepatic sinusoids, and mononuclear cell infiltration and inflammatory accumulation (black arrows). This shows that IDA can damage the liver and cause inflammatory responses. In the FE group, there were obvious lipid droplet vacuoles and inflammatory accumulation (black arrows), indicating that the intake of FeSO4 can cause fatty lesions and inflammatory responses. However, there was no significant difference between the intake of AKAF-Fe and the normal group. This shows that AKAF-Fe has a better intervention effect on liver damage.
[0098] Fig.10 The results showed that the effect of IDA on the spleen was mainly manifested by the formation of formed macrophages and inflammatory cells (red circles) accompanied by organ damage. Compared with the NC group, the FE group and the AKAF-FE group had no obvious lesions. However, formed macrophages and inflammatory cells (red circles) were also observed in the FE group, indicating that FeSO4 is toxic.
[0099] 11. Real-time fluorescence quantitative PCR experiment
[0100] Total RNA was extracted using Trozol reagent (Sangon, Shanghai, China). gDNA was removed and cDNA was synthesized on a T100 Thermal Cycler (BIO-RAD) using the Evo-MLV reverse transcription kit (Accurate Biology, Hunan, China) according to the instructions. Then, real-time fluorescence quantitative PCR was performed using the SYBR Green premix pro Taq HSqPCR kit (Accurate Biology, Hunan, China) using the SYBR Green I chimeric fluorescence method. -ΔΔCt The relative expression of genes was calculated by the method. The primer sequences used are shown in the table below.
[0101] Table 1 Primer sequences used
[0102]
[0103] (1) Effects of Antarctic krill amyloid fibril-iron complexes on iron homeostasis gene expression in mice
[0104] Experimental results: DMT1 is the main absorption pathway of non-heme iron in the intestine. IDA can cause an increase in the content of DMT1 mRNA. Fig.11 As shown in A, the expression of DMT1 mRNA in mice ingesting AKAF-Fe (AF group) was significantly different from that in the MD group, indicating that AKAF-Fe can have a positive effect on the expression of DMT1. FPN1 is a known non-heme iron exporter in mammals and is located in the basolateral membrane of the intestine. Fig.11 B shows that compared with the MD group, the expression level of FPN1 mRNA in the FE and AF groups was significantly reduced and returned to normal levels. There was a significant difference in the expression of FPN1 mRNA between the AF and FE groups, indicating that the intake of AKAF-Fe has a better recovery effect on FPN1.
[0105] (2) Effects of Antarctic krill amyloid fibril-iron complexes on the gene expression of inflammatory factors in the stomach of mice;
[0106] Experimental results: The inflammatory factors in the stomach were studied, including the pro-inflammatory factors IL-1β, IL-6 and the anti-inflammatory factor IL-10. Fig.12 As shown in the results, compared with the normal control group, the mRNA expression of IL-1β and IL-6 in the MD group was significantly increased, and the mRNA expression of IL-10 was significantly decreased, indicating that IDA caused an inflammatory response in the stomach. On the contrary, the intake of iron supplements can effectively reduce the content of IL-1β, IL-6 and increase IL-10. Among them, compared with the FE group, the intake of AKAF-Fe had a more positive regulatory effect on IL-1β, IL-6 and IL-10, which shows that AKAF-Fe can better relieve the inflammatory response of the stomach than FeSO4. Based on this, AKAF as a carrier can effectively protect the stomach from iron stimulation.
[0107] The embodiments provided above are not intended to limit the scope of the present invention, and the steps described are not intended to limit the execution order thereof. Those skilled in the art may make obvious improvements to the present invention in combination with existing common knowledge, which also fall within the scope of protection defined by the claims of the present invention.
Claims
1. A method for preparing Antarctic krill protein amyloid fiber-iron complex, characterized in that: The steps include: (1) Extraction of Antarctic krill protein Deionized water is added to the Antarctic krill meat, the pH is adjusted and then the mixture is stirred evenly, the supernatant is collected by centrifugation and the pH is adjusted to the isoelectric point of the Antarctic krill protein, and then the precipitate is collected by centrifugation, water is added to the obtained precipitate to adjust the pH, and the Antarctic krill protein is obtained by freeze-drying after dialysis; (2) Formation of amyloid fibrils in Antarctic krill Antarctic krill protein solution was prepared with deionized water, pH was adjusted after uniform stirring, and then heated and freeze-dried to obtain Antarctic krill protein amyloid fibers; (3) Preparation of Antarctic krill protein amyloid fibrils-iron complex Antarctic krill protein amyloid fibers are taken, deionized water is added to dissolve, ascorbic acid is added to adjust the pH, and then iron salt is added to react. After the reaction is completed, the supernatant is collected by centrifugation, anhydrous ethanol is added, and the precipitate is collected by centrifugation. After washing, it is dried to obtain Antarctic krill protein amyloid fiber-iron complex.
2. The method for preparing the Antarctic krill protein amyloid fiber-iron complex according to claim 1, characterized in that: In step (1), the method for preparing Antarctic krill protein specifically comprises the following steps: Add water to the Antarctic krill mince, the mass volume ratio of Antarctic krill meat to water is 1g:5-10mL, adjust the pH to 11-12.5, stir evenly for 2-3h, centrifuge at 8000-10000×g at 4°C for 10-15min, collect the supernatant, adjust the pH of the supernatant to the isoelectric point of Antarctic krill protein with 6-8mol / L hydrochloric acid solution, centrifuge at 8000-10000×g at 4°C for 10-15min, collect the precipitate, add 500-1000mL of water to the precipitate and stir evenly, adjust the pH to 7.0, put it into a 3500Da dialysis bag for dialysis for 24-48h, and freeze-dry to obtain Antarctic krill protein.
3. The method for preparing the Antarctic krill protein amyloid fiber-iron complex according to claim 1, characterized in that: In step (2), the pH is adjusted to 2.0-3.0; and the heating temperature is 70-90°C.
4. The method for preparing the Antarctic krill protein amyloid fiber-iron complex according to claim 1, characterized in that: In step (2), the mass concentration of the Antarctic krill protein solution is 1-5%.
5. The method for preparing the Antarctic krill protein amyloid fiber-iron complex according to claim 1, characterized in that: In step (3), the mass ratio of the added iron salt to the Antarctic krill protein amyloid fibers is 1:5 to 10:
1.
6. The method for preparing the Antarctic krill protein amyloid fiber-iron complex according to claim 1, characterized in that: In step (3), the reaction temperature is 20 to 60° C. and the reaction time is 20 to 60 min.
7. The method for preparing the Antarctic krill protein amyloid fiber-iron complex according to claim 1, characterized in that: In step (3), the pH is adjusted to 2.0-7.
0.
8. The method for preparing the Antarctic krill protein amyloid fiber-iron complex according to claim 1, characterized in that: In step (3), the mass ratio of iron salt to ascorbic acid is 1:1-2.
9. Antarctic krill protein amyloid fiber-iron complex prepared by the method according to any one of claims 1 to 8.
10. Use of the Antarctic krill protein amyloid fiber-iron complex according to claim 9 in the preparation of iron-rich food or iron supplement medicine.
Citation Information
Patent Citations
Method for preparing zeaxanthin dipalmitate high internal phase emulsion from protein amyloid fiber-polysaccharide complex
CN111467334A
Method for embedding and stabilizing carotene by taking egg lysozyme amyloid fiber as material
CN112106988A
Amyloid fiber-ferulic acid-chitosan double-network hydrogel as well as preparation method and application thereof
CN115353646A
Grifola frondosa small peptide and iron chelate as well as preparation method and application thereof
CN109680027A
Preparation method of euphausia superba peptide ferrous chelate
CN109897877A
Cited By
Method for improving iron ion loading rate of euphausia superba protein amyloid fiber and application
CN122056384A
